An analysis of anti-inflammatory cytokine IL-10 levels in the culture fluid of splenocytes derived from mice with lupus treated with TPC revealed increased IL-10 secretion by 12.5-fold compared to that from splenocytes originating from PBS-treated mice (P < 0.001). The gene discussed is IL10; the disease is systemic lupus erythematosus.